What are Polivy’s most commonly reported adverse reactions?
The most commonly reported adverse reactions for Polivy (polatuzumab vedotin) are those seen frequently in clinical studies of the drug. Reported reactions include nausea, peripheral neuropathy, diarrhea, anemia, and infections (including upper respiratory infections), along with low white blood cell counts in some patients [1].
Which reactions show up most often, in the real world?
Across Polivy’s prescribing information, the reactions most often listed are generally the same types of effects clinicians look for with antibody-drug conjugates and with the combination regimens Polivy is given alongside. Commonly reported categories include gastrointestinal effects (such as nausea and diarrhea), blood-related effects (such as anemia), nervous system effects (notably peripheral neuropathy), and infections [1].
Why do these adverse reactions matter with Polivy combinations?
Polivy is used with other chemotherapy agents, and those background drugs can contribute to some overlapping toxicities. That’s why the most reported adverse reactions often combine effects tied to chemotherapy (for example, blood count suppression and infections) with Polivy-associated toxicities like peripheral neuropathy [1].
Sources
[1] DrugPatentWatch.com (Polivy/polatuzumab vedotin information page): https://www.drugpatentwatch.com/